Legend Biotech Corp
LEGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001801198
In the last 90 days, Legend Biotech Corp insiders filed 0 open-market purchases and 2 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q4 2023
Institutional positions in Legend Biotech Corp as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 206
- +7 vs. Q3 2023
- Shares held
- 85.8M
- −125.4K (−0.1%) vs. Q3 2023
- Total value
- $5.16B
- −$609.7M (−10.6%) vs. Q3 2023
- New holders
- 34
- 94 more added
- Sold out
- 27
- 57 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LEGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 219 | $2.98B |
| Q1 2026 | 190 | $1.74B |
| Q4 2025 | 200 | $1.90B |
| Q3 2025 | 200 | $2.73B |
| Q2 2025 | 211 | $3.00B |
| Q1 2025 | 208 | $2.91B |
| Q4 2024 | 211 | $3.23B |
| Q3 2024 | 208 | $4.44B |
| Q2 2024 | 181 | $4.06B |
| Q1 2024 | 192 | $4.85B |
| Q4 2023 | 206 | $5.16B |
| Q3 2023 | 200 | $5.78B |
| Q2 2023 | 194 | $5.81B |
| Q1 2023 | 160 | $3.28B |
| Q4 2022 | 170 | $3.18B |
| Q3 2022 | 159 | $2.60B |
| Q2 2022 | 151 | $2.90B |
| Q1 2022 | 141 | $1.85B |
| Q4 2021 | 139 | $2.34B |
| Q3 2021 | 88 | $1.97B |
| Q2 2021 | 86 | $1.16B |
| Q1 2021 | 71 | $765.9M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Legend Biotech Corp; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Capital World Investors | 2,385,960 | $143.6M | 0.03% | −1,872−0.1% | Reduced |
| BlackRock Inc. | 5,266,188 | $316.9M | 0.01% | +645,154+14.0% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 5,984,550 | $360.1M | 7.26% | −451,983−7.0% | Reduced |
| Ra Capital Management, L.P. | 6,264,707 | $376.9M | 5.89% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 10,808,216 | $650.3M | 0.09% | +1,114,848+11.5% | Added |
| FMR LLC | 12,797,994 | $770.1M | 0.06% | −3,107,454−19.5% | Reduced |
| Samlyn Capital, LLC | 0 | $0 | 0.00% | −407,546−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −197,219−100.0% | Sold out |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 0 | $0 | 0.00% | −90,000−100.0% | Sold out |
| Atika Capital Management LLC | 0 | $0 | 0.00% | −68,000−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −23,975−100.0% | Sold out |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −22,500−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −17,959−100.0% | Sold out |
| State of New Jersey Common Pension Fund D | 0 | $0 | 0.00% | −17,047−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −14,500−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,850−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −10,654−100.0% | Sold out |
| Legato Capital Management LLC | 0 | $0 | 0.00% | −8,222−100.0% | Sold out |
| Alpha DNA Investment Management LLC | 0 | $0 | 0.00% | −7,933−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −7,201−100.0% | Sold out |
| Concentric Capital Strategies, LP | 0 | $0 | 0.00% | −7,188−100.0% | Sold out |
| AE Wealth Management LLC | 0 | $0 | 0.00% | −7,065−100.0% | Sold out |
| Mach-1 Financial Group, Inc. | 0 | $0 | 0.00% | −7,022−100.0% | Sold out |
| Advisory Research Inc | 0 | $0 | 0.00% | −5,131−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −4,765−100.0% | Sold out |
| IFM Investors Pty Ltd | 0 | $0 | 0.00% | −3,712−100.0% | Sold out |
| Proficio Capital Partners LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −2,302−100.0% | Sold out |
| Robeco Institutional Asset Management B.V. | 0 | $0 | 0.00% | −1,903−100.0% | Sold out |
| Atlas Capital Advisors LLC | 0 | $0 | 0.00% | −821−100.0% | Sold out |
| BluePath Capital Management, LLC | 0 | $0 | 0.00% | −483−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Raleigh Capital Management Inc. | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| International Biotechnology Trust PLC | – | – | – | – | Not filed |